These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9932155)

  • 1. PSA screening for prostate cancer: the current controversy--a viewpoint. Patient Outcomes Research Team for Prostatic Diseases.
    Barry MJ
    Ann Oncol; 1998 Dec; 9(12):1279-82. PubMed ID: 9932155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSA screening for prostate cancer: the current controversy.
    de Koning HJ; Schröder FH
    Ann Oncol; 1998 Dec; 9(12):1293-6. PubMed ID: 9932158
    [No Abstract]   [Full Text] [Related]  

  • 3. PSA screening--current controversy.
    Svetec D; Thompson IM
    Ann Oncol; 1998 Dec; 9(12):1283-8. PubMed ID: 9932156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for prostate cancer.
    Neal DE; Donovan JL
    Ann Oncol; 1998 Dec; 9(12):1289-92. PubMed ID: 9932157
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.
    Boyle P
    Ann Oncol; 1998 Dec; 9(12):1263-4. PubMed ID: 9932152
    [No Abstract]   [Full Text] [Related]  

  • 6. Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study.
    Zappa M; Ciatto S; Bonardi R; Mazzotta A
    Ann Oncol; 1998 Dec; 9(12):1297-300. PubMed ID: 9932159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?
    Duffy MJ
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):310-6. PubMed ID: 21525152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for prostate cancer with prostate-specific antigen: beware the biases.
    Bunting PS
    Clin Chim Acta; 2002 Jan; 315(1-2):71-97. PubMed ID: 11728412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
    Tawfik A
    Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
    Pron G
    Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma.
    Mistry K; Cable G
    J Am Board Fam Pract; 2003; 16(2):95-101. PubMed ID: 12665174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of clinically localized prostate cancer. Part I--observation or treatment?].
    Szelachowska J; Kornafel J; Gisterek I
    Pol Merkur Lekarski; 2006 Dec; 21(126):594-7. PubMed ID: 17405305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
    Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
    Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later.
    Pienta KJ
    Urology; 2009 May; 73(5 Suppl):S11-20. PubMed ID: 19375622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen screening: pro.
    Loeb S; Catalona WJ
    Curr Opin Urol; 2010 May; 20(3):185-8. PubMed ID: 20224413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
    Ito K
    Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
    [No Abstract]   [Full Text] [Related]  

  • 19. The prostate cancer pseudo-epidemic.
    Adami HO
    Acta Oncol; 2010 Apr; 49(3):298-304. PubMed ID: 20397765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.
    Wilt TJ
    Semin Urol Oncol; 2002 Feb; 20(1):10-7. PubMed ID: 11828353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.